Revive Therapeutics Ltd (RVVTF)

[Fress]

It's a $3.00 stock very near term masquerading as .30 stock.


A drug in phase 3 is valued any where between 300 million & 1.1 Billion I would argue that it's higher for a Covid-19 indication targeting patients with mild to moderate symptoms. The largest patient population.


The stock is extremely undervalued and the market will rectify its value in the coming days & weeks. Book it.


$RVVTF